Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Clarke J., Craig R. M., Saffro R., Murphy P., Yokoo H. Cytomegalovirus granulomatous hepatitis. Am J Med. 1979 Feb;66(2):264–269. doi: 10.1016/0002-9343(79)90543-6. [DOI] [PubMed] [Google Scholar]
- Finegold M. J., Carpenter R. J. Obliterative cholangitis due to cytomegalovirus: a possible precursor of paucity of intrahepatic bile ducts. Hum Pathol. 1982 Jul;13(7):662–665. doi: 10.1016/s0046-8177(82)80011-7. [DOI] [PubMed] [Google Scholar]
- Griffiths P. D. Cytomegalovirus and the liver. Semin Liver Dis. 1984 Nov;4(4):307–313. doi: 10.1055/s-2008-1040660. [DOI] [PubMed] [Google Scholar]
- Griffiths P. D., Grundy J. E. The status of CMV as a human pathogen. Epidemiol Infect. 1988 Feb;100(1):1–15. doi: 10.1017/s095026880006550x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grundy J. E., Shanley J. D., Griffiths P. D. Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet. 1987 Oct 31;2(8566):996–999. doi: 10.1016/s0140-6736(87)92560-8. [DOI] [PubMed] [Google Scholar]
- O'Grady J. G., Alexander G. J., Sutherland S., Donaldson P. T., Harvey F., Portmann B., Calne R. Y., Williams R. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet. 1988 Aug 6;2(8606):302–305. doi: 10.1016/s0140-6736(88)92356-2. [DOI] [PubMed] [Google Scholar]